GSK

American Chamber of Commerce to the European Union (AmChamEU)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
International Pharmaceutical Aerosol Consortium (IPAC)
Digital Europe
MedTech Europe
European Policy Centre (EPC)
Friends of Europe
Ambrosetti
European Roundtable for Industry (ERT)
RPP Group
British Chamber of Commerce EU & Belgium

None declared

Promotes their own interests or the collective interests of their members

Jan 2023 - Dec 2023

1,000,000€ - 1,249,999€

None declared

1,000,000€ - 1,249,999€

GSK is following the Transparency Register Code of Conduct and Implementing Guidelines. The organisation is also following the EFPIA Codes.
The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of employees and their salaries whose activities are considered in-scope.

None declared

N/A

Mainly via participation in events organised by think tanks and trade associations.

None declared

13 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

• Date	10 Oct 2024	Location	Brussels
  Subject	EB Summit
  Cabinet	Cabinet of President Ursula von der Leyen
  Attending	Peter van Kemseke (Cabinet member)
  Other Lobbyists	Amgen Inc

• Date	28 Apr 2021	Location	Brussels
  Subject	EU vaccine production and pandemic preparedness
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Maurits-Jan Prinz (Cabinet member)

• Date	11 Feb 2021	Location	webex
  Subject	vaccines
  DG	Health and Food Safety
  Attending	Sandra Gallina (Director-General)

• Date	31 May 2018	Location	Brussels
  Subject	Brexit preparedness
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)

• Date	23 Mar 2018	Location	Brussels
  Subject	IP regime generic manufacturers in the pharmaceutical industry
  Cabinet	Cabinet of Commissioner Pierre Moscovici
  Portfolio	Economic and Financial Affairs, Taxation and Customs
  Attending	Leila Fernandez-Stembridge (Cabinet member)

• Date	01 Dec 2017	Location	Brussels
  Subject	FTA implementation & transparency / trade relations with China, Turkey, Russia / importance of including vaccines in trade negotiations
  Cabinet	Cabinet of Vice-President Cecilia Malmström
  Portfolio	Trade
  Attending	Nele Eichhorn (Cabinet member) Maria Asenius (Cabinet member)

• Date	09 Nov 2017	Location	Brussels
  Subject	Innovation in the pharmaceutical sector, SPC, health technology assessments
  Cabinet	Cabinet of Vice-President Jyrki Katainen
  Portfolio	Jobs, Growth, Investment and Competitiveness
  Attending	Marika Lautso-Mousnier (Cabinet member)

• Date	26 Jun 2017	Location	Brussels
  Subject	Antimicrobial resistance (AMR)
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Carlos Moedas (Commissioner)

• Date	30 Sep 2015	Location	Brussels
  Subject	Vaccination
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Paula Duarte Gaspar (Cabinet member)

• Date	24 Sep 2015	Location	Brussels
  Subject	Challenges of the pharma industry
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Carlos Moedas (Commissioner)

• Date	18 May 2015	Location	Brussels
  Subject	Access to medicines in Africa
  Cabinet	Cabinet of Vice-President Cecilia Malmström
  Portfolio	Trade
  Attending	Cécile Billaux (Cabinet member)

• Date	16 Jan 2015	Location	PRAGUE, CZECH REPUBLIC
  Subject	Round Table on Gender Diversity
  Cabinet	Cabinet of Commissioner Věra Jourová
  Portfolio	Justice, Consumers and Gender Equality
  Attending	Věra Jourová (Commissioner)
  Other Lobbyists	Novartis International AG

• Date	05 Dec 2014	Location	Brussels
  Subject	Life sciences contribution to growth and jobs
  Cabinet	Cabinet of Vice-President Jyrki Katainen
  Portfolio	Jobs, Growth, Investment and Competitiveness
  Attending	Heidi Jern (Cabinet member) Aura Salla (Cabinet member)